Jeffrey N. Simmons

2018

In 2018, Jeffrey N. Simmons earned a total compensation of $5.4M as President, Chief Executive Officer and Director Elanco Animal Health, Inc at Lilly Eli & Co.

Compensation breakdown

Non-Equity Incentive Plan$907,450
Option Awards$1,119,445
Salary$775,185
Stock Awards$2,530,654
Other$46,511
Total$5,379,245

Simmons received $2.5M in stock awards, accounting for 47% of the total pay in 2018.

Simmons also received $907.5K in non-equity incentive plan, $1.1M in option awards, $775.2K in salary and $46.5K in other compensation.

Rankings

In 2018, Jeffrey N. Simmons' compensation ranked 1,811th out of 14,244 executives tracked by ExecPay. In other words, Simmons earned more than 87.3% of executives.

ClassificationRankingPercentile
All
1,811
out of 14,244
87th
Division
Manufacturing
644
out of 5,758
89th
Major group
Chemicals And Allied Products
210
out of 2,119
90th
Industry group
Drugs
165
out of 1,808
91st
Industry
Pharmaceutical Preparations
124
out of 1,382
91st
Source: SEC filing on March 22, 2019.

Simmons' colleagues

We found five more compensation records of executives who worked with Jeffrey N. Simmons at Lilly Eli & Co in 2018.

2018

David Ricks

Lilly Eli & Co

Chief Executive Officer

2018

Michael Harrington

Lilly Eli & Co

General Counsel

2018

Joshua Smiley

Lilly Eli & Co

Chief Financial Officer

2018

Daniel Skovronsky

Lilly Eli & Co

Chief Scientific Officer

2018

Enrique Conterno

Lilly Eli & Co

Senior Vice President and President, Lilly Diabetes and President, Lilly USA

News

You may also like